Cover Image
市場調查報告書

針頭安全注射器:市場預測

Needlestick Safety Injection Devices, 2014 - 2024

出版商 ROOTS ANALYSIS 商品編碼 316014
出版日期 內容資訊 英文 226 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
針頭安全注射器:市場預測 Needlestick Safety Injection Devices, 2014 - 2024
出版日期: 2014年10月08日 內容資訊: 英文 226 Pages
簡介

針頭安全注射器的市場今後預測將會受到正急速成長的注射用藥劑市場及安全注射器利用獎勵法規等推動成長。預測設計方面創新和高度安全性機制也將持續發展。

本報告提供針頭安全注射器的市場相關調查,為您彙整針扎事故的發生情形,相關法律,主要產品簡介,市場規模的變化與預測,各類型的明細,主要經營者簡介等資料。

第1章 序論

第2章 摘要整理

第3章 簡介

  • 背景
  • 針扎事故
  • 針頭安全器具:定義
  • OSHA:針頭安全器具的類別
  • 針頭安全器具:最佳特徵
  • 針頭安全器具:課題
  • 法律制度
    • 聯邦法
    • 州法
    • 國際法
佩佩如此多嬌,引無數花痴盡折腰,撿肥皂

第4章 市場概要

  • 概要
  • 安全注射器
  • 成本比較
  • 其他的設備
    • 安全血液回收/輸血套組
    • 自動注射器
      • 筆型注射器 vs 自動注射器
      • 自行注射器的安全選擇
    • Blunt Fill Needles
    • 無針注射技術

第5章 安全注射器

  • 概要
  • 安全注射器的零組件
  • 安全注射器的各種類型
  • 伸縮式注射器
  • 非伸縮式/屏蔽針頭注射器
  • 分析:各價格
  • 競爭環境的製圖
  • 產品簡介
    • RevVac的安全注射器
    • Unifill Syringe
    • FreeVac的安全注射器
    • VanishPoint的注射器
    • Mysafety Syringe
    • MedPro被動式安全性注射器
    • SafePro的Plus Safety Syringe
    • Syringex的安全注射器
    • UNIQSAFE的安全注射器
    • BakSnap的伸縮式安全注射器
    • BD的Safety-Lok注射器
  • 其他安全注射器

第6章 安全針

  • 概要
  • 安全針的各種類型
  • 活性機制別的分佈
  • 安全針清單
  • 分析:各價格
  • 產品簡介
    • K-Pack的Surshield Needle
    • NovaGuard
    • SurGuard3Hypodermic Syringe(附安全針)
    • BD的AutoShield Duo Pen Needle
    • BD的SafetyGlide Shielding Hypodermic Needle
  • 其他安全針

第7章 市場發展

  • 已填入安全裝置之上市藥品
  • 契約·聯盟等

第8章 市場規模與預測

  • 概要
  • 預測手法
  • 安全注射器整體市場的預測
  • 伸縮式安全注射器市場預測
  • 非伸縮式安全注射器市場預測

第9章 企業簡介

  • 概要
  • Unilife Corporation
  • West Pharmaceuticals
  • BD Medical
  • Smiths Medical
  • Catalent
  • Terumo Medical Corporation
  • Covidien

第10章 針頭相關的安全器具製造商

  • 概要
  • Revolutions Medical Corporation
  • Beipu
  • Formosa Medical Devices
  • UNIQSAFE Biomeditech Company
  • 完成化工

第11章 SWOT分析

第12章 採訪

第13章 總論

  • 傳統設備轉換到安全注射器
  • 由於技術性演進,這些器具維持成長
  • 數十億美元的急速成長市場
  • 彙整

附錄

圖表清單

目錄
Product Code: RA10023

With increasing awareness about occupational safety and growing concern on the prevention of needlestick injury, safety injection devices have gained increased attention from the manufacturers and healthcare professionals worldwide. The accelerated emergence of regulatory controls over the past few years have further ensured that manufacturers come up with modifications in the product design and integrated safety controls to meet the requirements.

Safety injection devices, which include safety syringes and safety needles, are designed to enhance safety of the drug administration process and eliminate needlestick injuries - a major cause of blood-borne infections. The current growth in the market for a variety of safety injection devices is primarily underpinned by the evolving needs of the patients and the requirement for better and safer syringe systems.

These devices have several advantages over traditional drug delivery systems. Most importantly, the addition of safety feature provides optimal protection to the healthcare practitioners and patients, reducing the risk of accidental needlestick injuries. Specifically, in case of a retractable syringe, the needle is locked into the barrel of the syringe and the entire assembly can be safely disposed of. The cost of disposal of a safety syringe is relatively much lower compared to a conventional syringe. Despite a marginally relatively higher purchase price, these devices are known to offer long term economic advantage if the consequences of a needlestick injury and associated treatment expenses are taken into consideration.

In addition to the existing established device manufacturers, the market has seen the presence of some relatively new players. These start-ups have recently introduced some important safety devices with innovative features. The need for improvement in safety mechanisms and functionality of the devices will continue to present positive growth prospects for the market in the foreseeable future.

Synopsis:

The ‘Needlestick Safety Injection Devices Market, 2014-2024’ report provides an extensive study of the growing market of safety injection devices. This includes safety syringes, safety needles and other add-on safety tools. Due to the recent surge of regulations and the need for injection safety at healthcare settings, safety injection devices have emerged as one of the key focus areas for device manufacturers. The market is characterized by the presence of around 70 safety injection devices providing optimal protection from needlestick injuries to the patients as well as caregivers. When compared to the conventional drug delivery systems, these devices offer several other advantages including convenient disposal and long-term economic advantage. The focus of this report is primarily to understand the governing trends and the likely future evolution of these devices over the next decade.

The report covers various aspects such as regulatory guidelines, market developments, recent partnerships and our opinion on the likely drivers which will influence the industry's evolution. In addition, we have provided a holistic view of the market landscape including detailed profiles of leading devices, key features and their comparative position vis-à-vis other devices. The future growth in the market will primarily be driven by the rapidly expanding injectable drugs market and regulatory legislations encouraging the use of safety injection devices. Innovation in design and advanced safety mechanisms will continue to present development prospects in the years ahead.

Despite some of these key benefits and a promising future, the study also highlights considerable challenges associated with the use and implementation of these devices. The modification in design and incorporation of safety features present operational challenges to the administrators. Furthermore, cost is yet another factor that can significantly restrain the market in the short term. However, as the sales volume gains momentum, prices are expected to come down which will further drive the uptake of such devices.

The base year for the report is 2013. The study provides short-midterm and long term market forecasts for the period 2014 - 2019 and 2019 - 2024, respectively. The research, analysis and insights presented in this report is backed by a deep understanding of key insights gathered from both secondary and primary research.

Example Highlights:

  • 1. During our research, we identified 72 safety injection devices manufactured by 39 companies. Out of these, 46 were safety syringes, followed by safety needles (17) and other add-on safety tools (9).
  • 2. Becton Dickinson, Covidien and Terumo Medical Corporation are amongst the pioneers in the safety injection devices industry. The market however is fragmented and 58% of the safety injection devices are manufactured by smaller companies.
  • 3. The use of safety syringes has been mandated in the US; Europe and other international markets are moving towards the use and adoption of these devices. In addition to the established companies in the US and the Europe, the market has witnessed the emergence of some regional players including Beipu, UNIQSAFE Biomeditech Company and Formosa Medical Devices.
  • 4. Technological advancements are likely to be one of the primary drivers of the market. Examples include the emergence of needleless systems and prefilled syringes with safety features.
  • 5. The global market for safety syringes is likely to grow at a CAGR of 9.0% during 2014 - 2024. Non-retractable syringes currently capture a larger share of the total market. However, it is anticipated that wider customer adoption and declining prices will likely result in retractable syringes gaining a larger share of the pie in the coming decade.

Research Methodology

Most of the data presented in this report has been gathered by secondary research. We have also conducted interviews with experts in the area (academia, industry, medical practice and other associations) to solicit their opinions on emerging trends in the market. This is primarily useful for us to draw out our own opinion on how the market will shape up across different regions and drug segments. Where possible, the available data has been checked for accuracy from multiple sources of information.

The secondary sources of information include

  • Annual reports
  • Investor presentations
  • SEC filings
  • Industry databases
  • News releases from company websites
  • Government policy documents
  • Other analysts' opinion reports

While the focus has been on forecasting the market over the coming ten years, the report also provides our independent view on various technological and non-commercial trends emerging in the industry. This opinion is solely based on our knowledge, research and understanding of the relevant market gathered from various secondary and primary sources of information.

Chapter Outlines

Chapter 2 provides an executive summary of the insights captured in our research. The summary offers a high level view on the likely evolution of safety injection devices.

Chapter 3 provides a general introduction on the safety injection devices. We have also covered, in detail, the concept behind needlestick injuries, regulatory landscape, categorization of safety devices and associated challenges with the use of such devices.

Chapter 4 identifies the various safety devices available in the market; these include safety syringes, safety needles and add-on safety tools. The chapter also provides details on some alternative needle based safety devices including safety blood collection/infusion sets, auto-injectors, blunt fill needles and needleless injection and connector systems.

Chapter 5 includes analysis of various safety syringes that are available in the market, with detailed description on retractable and non-retractable syringes. An in-depth review, including distribution by type of safety feature, mode of activation, and analysis by price, has been covered in this chapter. The chapter also includes a comprehensive section on product profiles wherein all the safety syringes identified have been explained, with information on the product development history, usage/mechanism and key advantages.

Chapter 6 focuses specifically on safety needles that are currently available in the market. It provides a comprehensive review of the key parameters related to these devices including the mode of activation and price. In addition, it includes profiles of all the safety needles we were able to identify in the research.

Chapter 7 analyzes the market developments with respect to safety injection devices. It discusses the drugs and therapeutic products that are marketed along with the safety devices. It also contains information about the partnerships in this field that have taken place in the past few years.

Chapter 8 presents a detailed ten year forecast for the safety syringes market. Due to the uncertainty surrounding some of the key assumptions, we have presented three different growth tracks outlined as conservative, base and optimistic scenarios.

Chapter 9 includes profiles of key companies active in the safety injection devices market. Each company profile includes information such as financial performance, product portfolio, recent developments and future growth outlook.

Chapter 10 provides information on the regional/other manufacturers which have been actively involved in the market. The chapter also contains a section on the comparison of product portfolio for these companies.

Chapter 11 provides the SWOT analysis of the safety injection devices market giving strategic insights to the major factors that are likely to drive future growth while also highlighting the weakness and threats that can negatively impact the industry's evolution.

Chapter 12 is a collection of transcripts of interviews conducted during the course of this study.

Chapter 13 summarizes the overall report. In this chapter, we provide a recap of the key takeaways and our independent opinion based on the research and analysis described in previous chapters.

Chapter 14 is an appendix which provides tabulated data and numbers for all the figures provided in the report.

Chapter 15 is an appendix which provides a list of companies and organizations mentioned in the report.

Table of Contents

1. PREFACE

  • 1.1. Scope of the Report
  • 1.2. Research Methodology
  • 1.3. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

  • 3.1. Context and Background
  • 3.2. Needlestick Injuries
    • 3.2.1. Incidence and Cost Burden
  • 3.3. Needle Safety Devices: Definition
  • 3.4. OSHA: Categorization of Needle Safety Devices
  • 3.5. Needle Safety Devices: Desirable Characteristics
  • 3.6. Needle Safety Devices: Challenges
  • 3.7. Regulatory Landscape
    • 3.7.1. Federal Regulations
      • 3.7.1.1. Needlestick Safety and Prevention Act
      • 3.7.1.2. Regional Compliance
    • 3.7.2. State Regulations
    • 3.7.3. International Regulations

4. MARKET OVERVIEW

  • 4.1. Chapter Overview
  • 4.2. Safety Injection Devices
    • 4.2.1. Safety Injection Devices: Distribution by Type
    • 4.2.2. Safety Injection Devices: Manufacturer's Landscape
  • 4.3. Cost Comparison
  • 4.4. Other Devices
    • 4.4.1. Safety Blood Collection / Infusion Sets
    • 4.4.2. Autoinjectors
      • 4.4.2.1. Pen Injectors vs. Autoinjectors
      • 4.4.2.2. Safety Options in Self Injectors
    • 4.4.3. Blunt Fill Needles
    • 4.4.4. Needle Free Injection Technology

5. SAFETY SYRINGES

  • 5.1. Chapter Overview
  • 5.2. Components of a Safety Syringe
  • 5.3. Types of Safety Syringes
  • 5.4. Retractable Syringes
    • 5.4.1. List of Retractable Syringes
  • 5.5. Non Retractable/ Needle Shield Syringes
    • 5.5.1. List of Non-Retractable Safety Syringes
  • 5.6. Analysis by Price
  • 5.7. Mapping the Competitive Landscape
  • 5.8. Product Profiles
    • 5.8.1. Section Overview
    • 5.8.2. RevVac Safety Syringe
      • 5.8.2.1. Introduction
      • 5.8.2.2. Product Description
      • 5.8.2.3. Development History
      • 5.8.2.4. Usage/Mechanism
      • 5.8.2.5. Advantages
    • 5.8.3. Unifill Syringe
      • 5.8.3.1. Introduction
      • 5.8.3.2. Product Description
      • 5.8.3.3. Development History
      • 5.8.3.4. Usage/Mechanism
      • 5.8.3.5. Advantages
    • 5.8.4. The FreeVac Safety Syringe
      • 5.8.4.1. Introduction
      • 5.8.4.2. Product Description
      • 5.8.4.3. Development History
      • 5.8.4.4. Usage/Mechanism
      • 5.8.4.5. Advantages
    • 5.8.5. VanishPoint Syringe
      • 5.8.5.1. Introduction
      • 5.8.5.2. Product Description
      • 5.8.5.3. Development History
      • 5.8.5.4. Usage/Mechanism
      • 5.8.5.5. Advantages
    • 5.8.6. Mysafety Syringe
      • 5.8.6.1. Introduction
      • 5.8.6.2. Product Description
      • 5.8.6.3. Development History
      • 5.8.6.4. Mechanism/Usage
      • 5.8.6.5. Advantages
    • 5.8.7. MedPro Passive Safety Syringe
      • 5.8.7.1. Introduction
      • 5.8.7.2. Product Description
      • 5.8.7.3. Development History
      • 5.8.7.4. Usage/Mechanism
      • 5.8.7.5. Advantages
    • 5.8.8. SafePro Plus Safety Syringe
      • 5.8.8.1. Introduction
      • 5.8.8.2. Product Description
      • 5.8.8.3. Development History
      • 5.8.8.4. Usage/Mechanism
      • 5.8.8.5. Advantages
    • 5.8.9. Syringex Safety Syringe
      • 5.8.9.1. Introduction
      • 5.8.9.2. Product Description
      • 5.8.9.3. Development History
      • 5.8.9.4. Usage/Mechanism
      • 5.8.9.5. Advantages
    • 5.8.10. UNIQSAFE Safety Syringe
      • 5.8.10.1. Introduction
      • 5.8.10.2. Product Description
      • 5.8.10.3. Development History
      • 5.8.10.4. Usage/Mechanism
      • 5.8.10.5. Advantages
    • 5.8.11. BakSnap Retractable Safety Syringe
      • 5.8.11.1. Introduction
      • 5.8.11.2. Product Description
      • 5.8.11.3. Usage/Mechanism
      • 5.8.11.4. Advantages
    • 5.8.12. BD Safety-Lok Syringe
      • 5.8.12.1. Introduction
      • 5.8.12.2. Product Description
      • 5.8.12.3. Development History
      • 5.8.12.4. Usage/Mechanism
      • 5.8.12.5. Advantages
  • 5.9. Other Safety Syringes
    • 5.9.1. SureSafe Retractable Syringe
    • 5.9.2. Medicina Safety Syringes
    • 5.9.3. Medigard Safety Syringes
    • 5.9.4. Elite Safety Syringe
    • 5.9.5. The Protectus Safety Syringe
    • 5.9.6. Q Stat Safety Syringe
    • 5.9.7. SecureTouch Syringe
    • 5.9.8. Ultra Safety Plus XL Safety Syringe
    • 5.9.9. Needle-Pro Edge Safety Device
    • 5.9.10. SOL-CARE® Luer Lock Safety Syringe
    • 5.9.11. SafeSnap Safety Syringe
    • 5.9.12. BD Integra Syringe with Retracting PrecisionGlide Needle
    • 5.9.13. Star ID device
    • 5.9.14. SurGuard3 Hypodermic Syringe with Safety Needle
    • 5.9.15. Wenzhou Safety Syringe
    • 5.9.16. Magellan Hypodermic Safety Needle & Syringe Combinations
    • 5.9.17. Monoject Safety Syringes
    • 5.9.18. ClickZip Needle Retractable Safety Syringe
    • 5.9.19. RauSafe
    • 5.9.20. Fulject Safety Syringe
    • 5.9.21. Epiphany Safe Shot Safety Syringe
    • 5.9.22. BD Safety Glide Syringe for Insulin, TB and Allergy

6. SAFETY NEEDLES

  • 6.1. Chapter Overview
  • 6.2. Types of Safety Needles
  • 6.3. Distribution by Mode of Activation
  • 6.4. List of Safety Needles
  • 6.5. Analysis by Price
  • 6.6. Product Profiles
    • 6.6.1. Section Overview
    • 6.6.2. K-Pack Surshield Needle
      • 6.6.2.1. Introduction
      • 6.6.2.2. Product Description
      • 6.6.2.3. Mechanism/Usage
      • 6.6.2.4. Advantages
      • 6.6.2.5. Current Status
    • 6.6.3. NovaGuard
      • 6.6.3.1. Introduction
      • 6.6.3.2. Product Description
      • 6.6.3.3. Mechanism/Usage
      • 6.6.3.4. Advantages
      • 6.6.3.5. Current Status
    • 6.6.4. SurGuard3 Hypodermic Syringe with Safety Needle
      • 6.6.4.1. Introduction
      • 6.6.4.2. Product Description
      • 6.6.4.3. Mechanism/Usage
      • 6.6.4.4. Advantages
    • 6.6.5. BD AutoShield Duo Pen Needle
      • 6.6.5.1. Introduction
      • 6.6.5.2. Product Description
      • 6.6.5.3. Mechanism/Usage
      • 6.6.5.4. Advantages
      • 6.6.5.5. Current Status
    • 6.6.6. BD SafetyGlide Shielding Hypodermic Needle
      • 6.6.6.1. Introduction
      • 6.6.6.2. Product Description
      • 6.6.6.3. Mechanism/Usage
      • 6.6.6.4. Advantages
      • 6.6.6.5. Current Status
  • 6.7. Other Safety Needles
    • 6.7.1. BD Eclipse Needle
    • 6.7.2. Wenzhou Safety Insulin Pen Needle
    • 6.7.3. The Click In Safety Shield System
    • 6.7.4. Magellan Hypodermic Safety Needles
    • 6.7.5. Novo Nordisk NovoFine Autocover
    • 6.7.6. Safety Tip needles
    • 6.7.7. Needle-Trap device
    • 6.7.8. Med-Lok Safety Needle
    • 6.7.9. Autosafe-Reflex Safety Needle

7. MARKET DEVELOPMENTS

  • 7.1. Marketed Drugs in/with Safety Devices
  • 7.2. Deals and Partnerships

8. MARKET SIZE AND FORECAST

  • 8.1. Chapter Overview
  • 8.2. Forecast Methodology
  • 8.3. Overall Safety Syringes Market, 2014-2024 (Value and Volume)
  • 8.4. Retractable Safety Syringes Market, 2014- 2024 (Value and Volume)
  • 8.5. Non-retractable Safety Syringes Market, 2014- 2024 (Value and Volume)

9. COMPANY PROFILES

  • 9.1. Chapter Overview
  • 9.2. Unilife Corporation
    • 9.2.1. Overview and Background
    • 9.2.2. Financial Performance
    • 9.2.3. Product Portfolio
      • 9.2.3.1. Unifill Platform of Prefilled Syringes
      • 9.2.3.2. EZMix Platform of Dual-Chamber Syringes (Drug Reconstitution Delivery Systems)
      • 9.2.3.3. Auto-Injector Platform
      • 9.2.3.4. Wearable Injector Platform
      • 9.2.3.5. Ocular Delivery Systems
      • 9.2.3.6. Novel Delivery Systems
    • 9.2.4. Recent Developments
      • 9.2.4.1. Partnership with Novartis
      • 9.2.4.2. Partnership with A Global Pharmaceutical Company (undisclosed)
      • 9.2.4.3. Partnership with Medimmune
      • 9.2.4.4. Partnership with Hikma
      • 9.2.4.5. Partnership with Sanofi
      • 9.2.4.6. Partnership with Biodel
    • 9.2.5. Future Outlook
  • 9.3. West Pharmaceuticals
    • 9.3.1. Overview and Background
    • 9.3.2. Financial Performance
    • 9.3.3. Product Portfolio
      • 9.3.3.1. Marketed Products
      • 9.3.3.2. Pipeline Products
    • 9.3.4. Recent Developments
      • 9.3.4.1. Advancing The Growth Of CZ Syringes
      • 9.3.4.2. Looking to Grow in Pharmerging Markets (Brazil, China, India)
      • 9.3.4.3. Agreement with Janssen Biotech
    • 9.3.5. Future Outlook
  • 9.4. BD Medical, A Segment Of Becton, Dickinson and Company
    • 9.4.1. Overview and Background
    • 9.4.2. Financial Performance
    • 9.4.3. Product Portfolio
    • 9.4.4. Recent Developments
      • 9.4.4.1. Agreement with Biodel
      • 9.4.4.2. Collaboration with World Health Organization (WHO)
      • 9.4.4.3. Launch of BD Sterifill Advance
      • 9.4.4.4. Entering the Generic Business
      • 9.4.4.5. Acquisition of Cato Software Solutions
      • 9.4.4.6. Acquisition of Safety Syringes
    • 9.4.5. Future Outlook
  • 9.5. Smiths Medical
    • 9.5.1. Overview and Background
    • 9.5.2. Financial Performance
    • 9.5.3. Product Portfolio
    • 9.5.4. Recent Developments
    • 9.5.5. Future Outlook
  • 9.6. Catalent
    • 9.6.1. Financial Performance
    • 9.6.2. Product Portfolio
    • 9.6.3. Recent Developments
    • 9.6.4. Future Outlook
  • 9.7. Terumo Medical Corporation
    • 9.7.1. Financial Performance
    • 9.7.2. Product Portfolio
    • 9.7.3. Recent Developments
      • 9.7.3.1. Agreement with CareFusion
      • 9.7.3.2. Growing Focus on Safety Devices
      • 9.7.3.3. Launch of SurGuard3
    • 9.7.4. Future Outlook
  • 9.8. Covidien
    • 9.8.1. Financial Performance
    • 9.8.2. Product Portfolio
    • 9.8.3. Future Outlook

10. REGIONAL/OTHER NEEDLE BASED SAFETY DEVICES MANUFACTURERS

  • 10.1. Chapter Overview
  • 10.2. Regional Safety Injection Device Manufacturers: Comparative Landscape
  • 10.3. Revolutions Medical Corporation
  • 10.4. Beipu
  • 10.5. Formosa Medical Devices
  • 10.6. UNIQSAFE Biomeditech Company
  • 10.7. Taisei Kako

11. SWOT ANALYSIS

  • 11.1. Chapter Overview
  • 11.2. Strengths
  • 11.3. Weaknesses
  • 11.4. Opportunities
  • 11.5. Threats

12. INTERVIEW TRANSCRIPTS

13. CONCLUSION

  • 13.1. Transition From Conventional Devices To Safety Injection Devices
  • 13.2. Technological Advancements Have Ensured That These Devices Continue to Gain Traction From Healthcare Practitioners And Patients Alike
  • 13.3. A Multi-Billion Dollar Rapidly Growing Market
  • 13.4. Concluding Remarks

14. APPENDIX 1: TABULATED DATA

15. APPENDIX 2: LIST OF COMPANIES

List of Figures:

  • Figure 3.1: Occurrence of Needlestick Injuries
  • Figure 4.1: Safety Injection Devices: Distribution by Type
  • Figure 4.2: Safety Injection Devices: Distribution by Companies
  • Figure 4.3: Safety Injection Devices: Leading Companies
  • Figure 5.1: Types of Safety Syringes
  • Figure 5.2: Safety Syringes: Distribution by Type
  • Figure 5.3: Safety Syringes: Distribution by Mode of Activation
  • Figure 5.4: Safety Syringes: Analysis by Price
  • Figure 5.5: Safety Syringes: Product Competitiveness Analysis
  • Figure 5.6: Safety Syringes: Product Profiling Framework
  • Figure 6.1: Safety Needles: Distribution by Mode of Activation
  • Figure 6.2: Safety Needles: Analysis by Price
  • Figure 6.3: Safety Needles: Product Profiling Framework
  • Figure 8.1: Overall Safety Syringes Market, Short-Mid Term (2014 - 2019): Base Scenario (Billion Units)
  • Figure 8.2: Overall Safety Syringes Market, Long Term (2019 - 2024): Base Scenario (Billion Units)
  • Figure 8.3: Overall Safety Syringes Market, Short-Mid Term (2014 - 2019): Base Scenario (USD Billion)
  • Figure 8.4: Overall Safety Syringes Market, Long Term (2019 - 2024): Base Scenario (USD Billion)
  • Figure 8.5: Number of Retractable Safety Syringes, Short-Mid Term (2014 - 2019): Base Scenario (Billion Units)
  • Figure 8.6: Number of Retractable Safety Syringes, Long Term (2019 - 2024): Base Scenario (Billion Units)
  • Figure 8.7: Retractable Syringes, 2014-2024: Distribution by Price Tiers
  • Figure 8.8: Retractable Safety Syringe Market, Short-Mid Term (2014 - 2019): Base Scenario (USD Billion)
  • Figure 8.9: Retractable Safety Syringe Market, Long Term (2019 - 2024): Base Scenario (USD Billion)
  • Figure 8.10: Number of Non-Retractable Safety Syringes, Short-Mid Term (2014 - 2019): Base Scenario (Billion Units)
  • Figure 8.11: Number of Non-Retractable Safety Syringes, Long Term (2019 - 2024): Base Scenario (Billion Units)
  • Figure 8.12: Non-retractable Syringes, 2014-2024: Distribution by Price Tiers
  • Figure 8.13: Non-Retractable Safety Syringe Market, Short-Mid Term (2014 - 2019): Base Scenario (USD Billion)
  • Figure 8.14: Non-Retractable Safety Syringe Market, Long Term (2019 -2024): Base Scenario (USD Billion)
  • Figure 9.1: Revenues, Unilife Corporation, FY 2011 - FY 2013 (USD ‘000)
  • Figure 9.2: West Pharmaceutical Services: Revenues, 2009-2013 (USD Million)
  • Figure 9.3: West Pharmaceutical Services: Revenues by Business Segments, 2011-2013 (USD Million)
  • Figure 9.4: Becton Dickinson: Revenues, 2009-2013 (USD Million)
  • Figure 9.5: Becton Dickinson: Revenues by Business Divisions, 2013 (USD Billion, %)
  • Figure 9.6: BD Medical: Revenues by Business Divisions, 2013 (USD Billion, %)
  • Figure 9.7: Smiths Group: Revenues, 2009-2013 (GBP Million)
  • Figure 9.8: Smiths Group: Revenues by Business Divisions, FY 2013 (GBP Million)
  • Figure 9.9: Smiths Medical: Revenues by Business Segments, FY 2012 - FY 2013 (GBP Million)
  • Figure 9.10: Catalent: Revenues, 2009-2013 (USD Million)
  • Figure 9.11: Catalent: Revenues by Business Segments, FY 2013 (USD Million)
  • Figure 9.12: Terumo Corporation: Revenues, FY09-FY 13 (JPY Billion)
  • Figure 9.13: Terumo Corporation: Revenues by Business Segments, FY 2013 (JPY Billion)
  • Figure 9.14: Covidien: Revenues, 2009-2013 (USD Million)
  • Figure 9.15: Covidien: Revenues by Business Segments, 2012-2013 (USD Million)
  • Figure 9.16: Covidien Medical Supplies: Revenues by Product Segments, 2013 (USD Million)
  • Figure 13.1: Safety Syringes Market (USD Billion): Comparative Scenarios, 2014, 2019 and 2024

List of Tables:

  • Table 3.1: Blood-borne Infections: Frequency of Occurrence
  • Table 3.2: Needle Safety: State Legislations
  • Table 4.1: List of Safety Injection Devices
  • Table 4.2: Cost Comparison: Safety Syringe and Conventional Syringe
  • Table 4.3: List of Safety Blood Collection / Infusion Sets
  • Table 4.4: Auto-injector/Pen-injector Systems Approved in 2013-2014
  • Table 4.5: Auto-injector/Pen-injector Systems (Using Prefilled Syringes) Available in the Market
  • Table 4.6: List of Blunt Fill Needles
  • Table 4.7: List of Needleless Injection Systems
  • Table 5.1: List of Retractable Safety Syringes
  • Table 5.2: Non Retractable Syringes: Disadvantages
  • Table 5.3: List of Non-Retractable Safety Syringes
  • Table 5.4: Safety Syringes: Purchase Price
  • Table 5.5: VanishPoint Syringe: Needle Size Description
  • Table 5.6: MySafety Syringe: Needle Size Description
  • Table 5.7: MySafety Syringe: Approval History
  • Table 5.8: Difference between SafePro Series and SafePro Plus Series
  • Table 5.9: SafePro Plus Safety Syringe: Needle Size Description
  • Table 5.10: UNIQSAFE Safety Syringe: Needle Size Description
  • Table 5.11: BD Safety-Lok Syringe: Needle Size Description
  • Table 6.1: List of Active Safety Needles
  • Table 6.2: List of Passive Safety Needles
  • Table 6.3: Safety Needles: Purchase Price
  • Table 6.4: K-Pack Surshield: Key Specifications
  • Table 6.5: Difference betweenSurGuard3 and SurGuard2 Safety Needle
  • Table 6.6: SurGuard3 Safety Needle: Needle Size Description
  • Table 6.7: BD SafetyGlide Shielding Hypodermic Needle: Key Specifications
  • Table 6.8: BD SafetyGlide Hypodermic Shielding Needle: Needle Size Description
  • Table 7.1: List of Marketed Drugs in/with Safety Devices
  • Table 7.2: Safety Injection Devices: Deals and Partnerships
  • Table 8.1: Retractable Syringes: Price Points
  • Table 8.2: Non-retractable Syringes: Price Points
  • Table 9.1: Becton Dickinson: List of Safety Injection Devices
  • Table 9.2: Terumo: Financial Targets of Mid-term Plan
  • Table 10.1: Regional Safety Injection Device Manufacturers: Comparison of Product Portfolio
  • Table 11.1: SWOT Analysis
  • Table 11.2: Recall of Autoinjectors
  • Table 11.3: Prefilled Syringe Recalls, 2003-2014
  • Table 13.1: Safety Syringes: Analysis by Volume
  • Table 14.1: Safety Injection Devices: Distribution by Type
  • Table 14.2: Safety Injection Devices: Distribution by Companies
  • Table 14.3: Safety Injection Devices: Leading Companies
  • Table 14.4: Safety Syringes: Distribution by Type
  • Table 14.5: Safety Syringes: Distribution by Mode of Activation
  • Table 14.6: Safety Needles: Distribution by Mode of Activation
  • Table 14.7: Overall Safety Syringes Market, Short-Mid Term (2014 - 2019): Base Scenario (Billion Units)
  • Table 14.8: Overall Safety Syringes Market, Long Term (2019 - 2024): Base Scenario (Billion Units)
  • Table 14.9: Overall Safety Syringes Market, Short-Mid Term (2014 - 2019): Conservative Scenario (Billion Units)
  • Table 14.10: Overall Safety Syringes Market, Long Term (2019 - 2024): Conservative Scenario (Billion Units)
  • Table 14.11: Overall Safety Syringes Market, Short-Mid Term (2014 - 2019): Optimistic Scenario (Billion Units)
  • Table 14.12: Overall Safety Syringes Market, Long Term (2019 - 2024): Optimistic Scenario (Billion Units)
  • Table 14.13: Overall Safety Syringes Market, Short-Mid Term (2014 - 2019): Base Scenario (USD Billion)
  • Table 14.14: Overall Safety Syringes Market, Long Term (2019 - 2024): Base Scenario (USD Billion)
  • Table 14.15: Overall Safety Syringes Market, Short-Mid Term (2014 - 2019): Conservative Scenario (USD Billion)
  • Table 14.16: Overall Safety Syringes Market, Long Term (2019 - 2024): Conservative Scenario (USD Billion)
  • Table 14.17: Overall Safety Syringes Market, Short-Mid Term (2014 - 2019): Optimistic Scenario (USD Billion)
  • Table 14.18: Overall Safety Syringes Market, Long Term (2019 - 2024): Optimistic Scenario (USD Billion)
  • Table 14.19: Number of Retractable Safety Syringes, Short-Mid Term (2014 - 2019): Base Scenario (Billion Units)
  • Table 14.20: Number of Retractable Safety Syringes, Long Term (2019 - 2024): Base Scenario (Billion Units)
  • Table 14.21: Number of Retractable Safety Syringes, Short-Mid Term (2014 - 2019): Conservative Scenario (Billion Units)
  • Table 14.22: Number of Retractable Safety Syringes, Long Term (2019 - 2024): Conservative Scenario (Billion Units)
  • Table 14.23: Number of Retractable Safety Syringes, Short-Mid Term (2014 - 2019): Optimistic Scenario (Billion Units)
  • Table 14.24: Number of Retractable Safety Syringes, Long Term (2019 - 2024): Optimistic Scenario (Billion Units)
  • Table 14.25: Retractable Safety Syringe Market, Short-Mid Term (2014 - 2019): Base Scenario (USD Billion)
  • Table 14.26: Retractable Safety Syringe Market, Long Term (2019 - 2024): Base Scenario (USD Billion)
  • Table 14.27: Retractable Safety Syringe Market, Short-Mid Term (2014 - 2019): Conservative Scenario (USD Billion)
  • Table 14.28: Retractable Safety Syringe Market, Long Term (2019 - 2024): Conservative Scenario (USD Billion)
  • Table 14.29: Retractable Safety Syringe Market, Short-Mid Term (2014 - 2019): Optimistic Scenario (USD Billion)
  • Table 14.30: Retractable Safety Syringe Market, Long Term (2019 - 2024): Optimistic Scenario (USD Billion)
  • Table 14.31: Number of Non-Retractable Safety Syringes, Short-Mid Term (2014 - 2019): Base Scenario (Billion Units)
  • Table 14.32: Number of Non-Retractable Safety Syringes, Long Term (2019 - 2024): Base Scenario (Billion Units)
  • Table 14.33: Number of Non-Retractable Safety Syringes, Short-Mid Term (2014 - 2019): Conservative Scenario (Billion Units)
  • Table 14.34: Number of Non-Retractable Safety Syringes, Long Term (2019 - 2024): Conservative Scenario (Billion Units)
  • Table 14.35: Number of Non-Retractable Safety Syringes, Short-Mid Term (2014 - 2019): Optimistic Scenario (Billion Units)
  • Table 14.36: Number of Non-Retractable Safety Syringes, Long Term (2019 - 2024): Optimistic Scenario (Billion Units)
  • Table 14.37: Non-Retractable Safety Syringe Market, Short-Mid Term (2014 - 2019): Base Scenario (USD Billion)
  • Table 14.38: Non-Retractable Safety Syringe Market, Long Term (2019 - 2024): Base Scenario (USD Billion)
  • Table 14.39: Non-Retractable Safety Syringe Market, Short-Mid Term (2014 - 2019): Conservative Scenario (USD Billion)
  • Table 14.40: Non-Retractable Safety Syringe Market, Long Term (2019 - 2024): Conservative Scenario (USD Billion)
  • Table 14.41: Non-Retractable Safety Syringe Market, Short-Mid Term (2014 - 2019): Optimistic Scenario (USD Billion)
  • Table 14.42: Non-Retractable Safety Syringe Market, Long Term (2019 - 2024): Optimistic Scenario (USD Billion)
  • Table 14.43: Revenues, Unilife Corporation, FY 2011 - FY 2013 (USD ‘000)
  • Table 14.44: West Pharmaceutical Services: Revenues, 2009-2013 (USD Million)
  • Table 14.45: West Pharmaceutical Services: Revenues by Business Segments, 2011-2013 (USD Million)
  • Table 14.46: Becton Dickinson: Revenues, 2009-2013 (USD Million)
  • Table 14.47: Becton Dickinson: Revenues by Business Divisions, 2013 (USD Billion, %)
  • Table 14.48: BD Medical: Revenues by Business Segments, 2013 (USD Billion, %)
  • Table 14.49: Smiths Group: Revenues, 2009-2013 (GBP Million)
  • Table 14.50: Smiths Group: Revenues by Business Divisions, FY 2013 (GBP Million)
  • Table 14.51: Smiths Medical: Revenues by Business Segments, FY 2012 - FY 2013 (GBP Million)
  • Table 14.52: Catalent: Revenues, 2009-2013 (USD Million)
  • Table 14.53: Catalent: Revenues by Business Divisions, FY 2013 (USD Million)
  • Table 14.54: Terumo Corporation: Revenues, FY09-FY 13 (JPY Billion)
  • Table 14.55: Terumo Corporation: Revenues by Business Segments, FY 2013 (JPY Billion)
  • Table 14.56: Covidien: Revenues, 2009-2013 (USD Million)
  • Table 14.57: Covidien: Revenues by Business Segments, 2012-2013 (USD Million)
  • Table 14.58: Covidien Medical Supplies: Revenues by Product Segments, 2013 (USD Million)
  • Table 14.59: Safety Syringes Market (USD Billion) Forecast: 2014, 2019 and 2024

List of Companies

The following companies have been mentioned in this report.

  • 1. Activa
  • 2. AGN Tech
  • 3. AMB
  • 4. Antares Pharma
  • 5. Applied Medical Technology
  • 6. Aptar Pharma
  • 7. Aradigm Corporation
  • 8. AstraZeneca
  • 9. Autosafe-Reflex
  • 10. AxelBioCorp
  • 11. B. Braun Medical Inc.
  • 12. Bang and Olufsen
  • 13. Bard Access Systems
  • 14. Becton Dickinson
  • 15. Beipu
  • 16. Bespak
  • 17. Biodel
  • 18. Bioject Medical Technologies, Inc.
  • 19. Cardinal Health Nuclear Pharmaceutical Services
  • 20. CareFusion
  • 21. Catalent
  • 22. Cato Software Solutions
  • 23. CeifiT
  • 24. Churchill Medical Systems
  • 25. Covidien (Kendall Healthcare)
  • 26. DMC Medical
  • 27. DuoProSS Meditech Corp
  • 28. Elcam Medical
  • 29. EMD Serono/Pfizer
  • 30. Eternity Healthcare
  • 31. Ethicon, Inc.
  • 32. Evans Enterprise
  • 33. Formosa Medical Devices
  • 34. Globe Medical Tech, Inc.
  • 35. Greiner bio-one
  • 36. Haselmeier
  • 37. Health for personal Care
  • 38. Hectare Systems
  • 39. Hikma Pharmaceuticals
  • 40. Hospira
  • 41. ICU Medical
  • 42. Injex - Equidyne Systems
  • 43. Innovate UK
  • 44. Inviro Medical
  • 45. ITL (Innovating Technologies for Life) North America
  • 46. Janssen Biotech
  • 47. Kaleo Inc.
  • 48. Kawasumi Laboratories
  • 49. Med-Design Corporation
  • 50. Medex
  • 51. Medical Device Manufacturer (Thailand) Ltd
  • 52. MedicalChain International Corporation (MCI)
  • 53. Medicina
  • 54. Medigard
  • 55. Mediject
  • 56. MEDIpoint Inc.
  • 57. Medisytems, a NxStage Company
  • 58. Medpro Safety Products
  • 59. Meridian
  • 60. Microsharp Needles Pvt. Limited
  • 61. National Medical Products, Inc.
  • 62. New Wave Surgical Corp
  • 63. Nexus Medical
  • 64. Nipro
  • 65. Novo Nordisk A/S
  • 66. Owen Mumford
  • 67. PA Consulting
  • 68. Penjet corporation
  • 69. PlastefInvestissements SA
  • 70. Polymed Medical Devices
  • 71. Protectus Medical Devices, Inc.
  • 72. Q Stat
  • 73. Raumedic
  • 74. Retractable Technologies, Inc.
  • 75. Revolutions Medical Corporation Inc.
  • 76. Rexam Pharma
  • 77. SafeShot Technologies
  • 78. Safety Medical Products Limited
  • 79. Safety Medical Supply Intl.
  • 80. Safety Syringes, Inc
  • 81. Sanofi
  • 82. Santa Monica
  • 83. Sarstedt, Inc.
  • 84. Scandinavian Health Limited (SHL Medical)
  • 85. Schreiner MediPharm
  • 86. Scivanta Medical Corporation
  • 87. Septodont, Inc.
  • 88. SHL Medical
  • 89. SHPI
  • 90. Smiths Medical
  • 91. Sol-Millennium
  • 92. STA.MED
  • 93. Star Syringe Ltd
  • 94. Suzuken Co., Ltd.
  • 95. Synthecon
  • 96. Syringex Medical
  • 97. Taisei Kako
  • 98. Terumo Medical Corp.
  • 99. The Medical House
  • 100. U.S. Medical Instruments
  • 101. Unilife Corporation
  • 102. UNIQSAFE Biomeditech Company
  • 103. Valeritas
  • 104. Vätterledens Invest
  • 105. Vigmed
  • 106. Vital Signs
  • 107. Weimer Pharma
  • 108. West Pharmaceutical Solutions
  • 109. Westmed, Inc.
  • 110. Ypsomed
  • 111. ZEON
  • 112. Zhejiang Zheda Medical Instrument Co. Ltd.
Back to Top